Skip to main content
Henry Sacks, MD, Geriatrics, New York, NY, The Mount Sinai Hospital

HenrySSacksMD

Geriatrics New York, NY

Profe, Biomathematical Sciences, Icahn School of Medicine at Mount Sinai

Dr. Sacks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sacks' full profile

Already have an account?

Education & Training

  • University of Connecticut
    University of ConnecticutFellowship, Infectious Disease, 1977 - 1979
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 1975 - 1977
  • Albany Medical College
    Albany Medical CollegeClass of 1975

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1979 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Why Do September 11 First Responders Have a High Cancer Rate?
    Why Do September 11 First Responders Have a High Cancer Rate?July 28th, 2020
  • Sept. 11 Responders May Be at Heightened Risk of Developing Leukemia
    Sept. 11 Responders May Be at Heightened Risk of Developing LeukemiaJanuary 14th, 2020

Grant Support

  • Meta-Analysis Of CAM Therapies For HIVNational Center For Complementary &Alternative Medicine2010–2012
  • Effects Of A Dietary Supplement On Non-Small Cell Lung Cancer PatientsNational Center For Research Resources2009
  • Women'S Interagency HIV Study(Wihs)National Center For Research Resources2007
  • A Pilot Study Of Silymarin In Patients With HIV And HCVNational Center For Research Resources2005–2007
  • Women'S Interagency HIV Study(Wihs) (National Center For Research Resources2006
  • WIHS Cardiovascular ComponentNational Center For Research Resources2006
  • Prolong The Survival Of Nscl Patients By A PhytomixNational Center For Complementary &Alternative Medicine2004–2006
  • Women'S Interagency HIV Study (WIHS)National Center For Research Resources2005
  • Pilot Trial Of Silymarin In Patients With HCV And HIVNational Institute Of Nursing Research2004–2005
  • Leadership Award In Complementary And Alternative MedicNational Center For Complementary &Alternative Medicine2001–2005
  • Collaborative HIV/AIDS Development Project IndiaNational Center For Complementary &Alternative Medicine2003–2004
  • Protease Inhibitor/Methadone Metabolism In HIV InfectionNational Center For Research Resources2000–2002
  • PI &Nnrti In HIV InfectionNational Center For Research Resources2000–2002
  • Phase III Trial Of Efavirenz Or Nelfinavir Lamivudine &ZidovudineNational Center For Research Resources2000–2002
  • ACTG 323--Fluconazole As Chronic Supp. Therapy Vs. Episodic Therapy In HIV+ PTSNational Center For Research Resources2000–2002
  • ACTG 309 Pharmacokinetics Of Antituberculosis Agents In HIV InfectedNational Center For Research Resources2000–2002
  • ACTG 398 Phase II Trial Of Amprenavir Abacavir, Efavirenz &AdefovirNational Center For Research Resources1999–2002
  • ACTG 372 Phase II Study Of Prolongation Of Virologic Rollover For ACTNational Center For Research Resources1999–2002
  • ACTG 362 Trial To Determine Efficacy Of Azithromycin ProphylaxisNational Center For Research Resources1999–2002
  • ACTG 328--Study Of Intermt. Rhil-2 Compared To HaartNational Center For Research Resources1999–2002
  • ACTG 301 Trial Of Memantine For AIDS Dementia Complex (ADC)National Center For Research Resources1999–2002
  • ACTG 291--Trial Of RU Human Nerve GF In HIV Assoc. Perph. NeuropathyNational Center For Research Resources1999–2002
  • ACTG 364--Comparison Of The Virologic Efficacy Of Nelfinavir AND/OR DMP 266National Center For Research Resources1998–2002
  • Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Outreach AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Neurology AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1996–2001
  • Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
  • Viral Activation Transfusion StudyDivision Of Blood Diseases And Resources1995–2001
  • Phase III Trial Of Efavirenz Or Nelfinavir , Lamivudine / ZidovudineNational Center For Research Resources1999
  • Pharmacokinetics Of Antituberculosis Agents In HIV Infected PersonsNational Center For Research Resources1999
  • Fluconazole As Supp. Therapy Vs. Episodic Therapy In HIV+ PTSNational Center For Research Resources1999
  • Women'S Interagency HIV Study (WIHS)National Center For Research Resources1998–1999
  • ACTG 368--Phase II Trial Of 1592U89 In Combination With Indinavir SulfateNational Center For Research Resources1998–1999
  • Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1997–1999
  • ACTG 320--Study Of Indinavir Sulfatae With OPEN Label Zidovudine &LamivudineNational Center For Research Resources1997–1999
  • ACTG 302--Virologic Responses To New Nucleoside Regimens After Prolonged ZDVNational Center For Research Resources1997–1999
  • ACTG 288--Follow UP Of Women Participating In ACTG 076National Center For Research Resources1997–1999
  • ACTG 254--Micronized Atovaquone &Azithromycin VS Trimethoprim/SulfamethaxzoleNational Center For Research Resources1997–1999
  • ACTG 245--Combination Antiretroviral Therapy In Children &Adolescents With HIVNational Center For Research Resources1997–1999
  • ACTG 219--Multicenter Trial Of The AIDS Clinical Trials GroupNational Center For Research Resources1997–1999
  • ACTG 200--A Preenrollment Protocol For HIV Infected AdolescentsNational Center For Research Resources1997–1999
  • ACTG 185--Phase Iii--Hivig For Prevention Of Maternal/Fetal HIV TransmissionNational Center For Research Resources1997–1999
  • Randomized Comparative Study Of Combined ZDV 3TC VS DDI Monotherapy VS Zdv/DdiNational Center For Research Resources1996–1999
  • ACTG 328--Phase II Study Of Intermittent Recombinant Human Interleukin 2National Center For Research Resources1998
  • ACTG 323--Phase IV Randomized Study Of The Use Of FluconazoleNational Center For Research Resources1998
  • ACTG 291--Phase II Trial Of Recombinant Human Nerve Growth FactorNational Center For Research Resources1997–1998
  • ACTG 261--Phase II Double Blind Study Of Delavirdine, Zidovudine, And DidanosineNational Center For Research Resources1997
  • ACTG 251--Thalidomide For Treatment Of Oral And Esophageal UlcersNational Center For Research Resources1997
  • ACTG 250--Phase I Study--Nevirapine In HIV I Infected Pregnant Women And NeonatesNational Center For Research Resources1997
  • ACTG 243--Phase II Study Comparing Antiretroviral Therapy Alone Or With ARA-CNational Center For Research Resources1997
  • ACTG 242--Phase II/III Double Blind Study Of Amitriptyline And MexiletineNational Center For Research Resources1997
  • ACTG 240--Randomized Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources1997
  • ACTG 222--Treatment Of Mycobacterium Tuberculosis In HIV InfectionNational Center For Research Resources1997
  • ACTG 215--Phase I Study Of Tnp470 In Treatment Of AIDS Associated Kaposis SarcomaNational Center For Research Resources1997
  • ACTG 206--Randomized Phase II Trial Of Interferon With Didanosine In Kaposis SarcNational Center For Research Resources1997
  • ACTG 175--Monotherapy VS Combination Therapy With Nucleoside Analogues In HIVNational Center For Research Resources1997
  • ACTG 076--Safety &Tolerance Of ZDV For Prevention Of Maternal/Fetal HIV InfectioNational Center For Research Resources1997
  • Womens Interagency HIV StudyNational Center For Research Resources1996–1997
  • Four-Arm Study Comparing Combination To Monthly Alternating Nucleoside TherapyNational Center For Research Resources1996–1997
  • Early Diagnosis Of Pediatric HIV InfectionNational Center For Research Resources1993–1997
  • Pediatric AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1996
  • Two Arm Study Micronized Atovaquone Azithromycin VS Trimethoprim/SulfamethaxzoleNational Center For Research Resources1996
  • Randomized Double Blind Trial Of Bw256u87 ProphylaxisNational Center For Research Resources1996
  • Randomized Comparative Study Of Daily Dapsone And Daily Atovaquone Against PCPNational Center For Research Resources1996
  • Phase III Randomized--Hivig For Prevention Of Maternal Fetal HIV TransmissionNational Center For Research Resources1996
  • Phase III Randomized Trial Of Low Dose M Bacod Chemotherapy VS Standard DoseNational Center For Research Resources1996
  • Phase II/III Double Blind Study Of Amitriptyline And Mexiletine--Hiv InfectionNational Center For Research Resources1996
  • Phase II Multicenter Study Comparing Antiretroviral Therapy Alone To ARACNational Center For Research Resources1996
  • Phase II Double Blind Study Of Delavirdine, Zidovudine, And DidanosineNational Center For Research Resources1996
  • Phase I Study--Nevirapine In HIV I Infected Pregnant Women And NeonatesNational Center For Research Resources1996
  • Phase I Study Of Tnp470 In The Treatment Of AIDS Associated Kaposis SarcomaNational Center For Research Resources1996
  • Follow UP Of Women Participating In ACTG 076National Center For Research Resources1996
  • Combination Of Zidovudine, Didanosine, And Double Blinded NevirapineNational Center For Research Resources1996
  • Combination Antiretroviral Therapy In Children &Adolescents With Advanced HIVNational Center For Research Resources1996
  • A Randomized Phase II Trial Of Interferon With Didanosine In Kaposi'S SarcomaNational Center For Research Resources1996
  • Treatment Of Mycobacterium Tuberculosis In HIV InfectionNational Center For Research Resources1995–1996
  • Thalidomide For Treatment Of Ulcers And HIV ViremiaNational Center For Research Resources1995–1996
  • Safety &Tolerance Of ZDV For Prevention Of Maternal-Fetal HIV InfectionNational Center For Research Resources1995–1996
  • Randomized Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources1995–1996
  • Multicenter Trial Of The AIDS Clinical Trials GroupNational Center For Research Resources1995–1996
  • Trial Of ZDV VS DDI VS Zdv+Ddi In Symptomatic HIV Infected ChildrenNational Center For Research Resources1994–1996
  • Study To Evaluate Activity Of Dideoxycytidine In Combination With ZidovudineNational Center For Research Resources1994–1996
  • DDC Alone Or Ddc/Zdv Combination VS Zidovudine Alone In Patients With HIVNational Center For Research Resources1994–1996
  • Clarithromycin VS Rifabutin VS Combination Of Clarithromycin PLUS RifabutinNational Center For Research Resources1994–1996
  • Pediatric AIDS Clinical ResearchNational Institute Of Allergy And Infectious Diseases1993–1996
  • Monotherapy VS Combination Therapy With Nucleoside Analogues In HIV PersonsNational Center For Research Resources1993–1996
  • Double Blind Comparison Of ZDV VS D4T For Patients With HIV InfectionNational Center For Research Resources1993–1996
  • Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–1996
  • Phase II Double-Blind Study Of Sc-49483 In Combination With ZidovudineNational Center For Research Resources1995
  • Phase II Double-Blind Study Of Delavirdine, Zidovudine, And DidanosineNational Center For Research Resources1995
  • Combination Of Zidovudine, Didanosine, And Double-Blinded NevirapineNational Center For Research Resources1995
  • A Randomized Phase 11 Trial Of Interferon With Didanosine In Kaposi'S SarcomaNational Center For Research Resources1995
  • Meta Analysis Of The AIDS LiteratureNational Institute Of Mental Health1994–1995
  • AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
  • Tolerance Of High VS Low Dose Zidovudine Administered To Children With HIVNational Center For Research Resources1994–1995
  • Three-Arm Study Comparing Combination To Monthly Alternating Nucleoside TherapyNational Center For Research Resources1994–1995
  • Safety And Efficacy Of ZDV For Asymptomatic HIV Infected IndividualsNational Center For Research Resources1994–1995
  • Randomized Double-Blind Trial Of BW 256u87 ProphylaxisNational Center For Research Resources1994–1995
  • Pediatric AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1993–1995
  • Trial Of Nimodipine For AIDS Dementia Complex With ZidovudineNational Center For Research Resources1993–1995
  • Feasibility Of Fluconazole For Relapse Of Histoplasmosis In Patients With AIDSNational Center For Research Resources1993–1995
  • Safety &Tolerance Of Oral Zidovudine In Hiv-Infected Pregnant Women TNational Center For Research Resources1994
  • Evaluation Of SQ 32,756 (Bv-Arau) VS Acyclovir In The Treatment Of Herpes ZosterNational Center For Research Resources1994
  • Combination Of Zidovudine, Didanosine, And Doubl-Blinded NevirapineNational Center For Research Resources1994
  • A Randomized Phase 11 Trial Of Interferon With Didanosine...Kaposi'S SarcomaNational Center For Research Resources1994
  • Trial Of 2',3'-Dideoxyinosine In Children With Symptomatic HIVNational Center For Research Resources1993–1994
  • Rifampin, Ciprofloxacin,...Mycobacterium Avium Infection In HIV InfectionNational Center For Research Resources1993–1994
  • Prophylaxis Against MTB In Patients Infected With HIVNational Center For Research Resources1993–1994
  • Combination Chemotherapy And DDI Or DDC In The Treatment Of Kaposi'S SarcomaNational Center For Research Resources1993–1994
  • Phase II Study Comparing 2'3'-Ddi And Zidovudine Therapy In PTS With AIDS Or ARCNational Center For Research Resources1992–1994
  • Dapsone/Trimethoprim &Clindamycin/Primaquine VS Trimethoprim/SulfamethoxazoleNational Center For Research Resources1992–1994
  • Bmy-27857 (2'3'-Didehydro-3'-Deoxythymidine, D4t) Administered To HIV+ PatientsNational Center For Research Resources1992–1994
  • Early Diagnosis Of Pediatric HIV InfectionNational Institute Of Allergy And Infectious Diseases1991–1994
  • Gamma Globulin And AZT In Children With HIV InfectionNational Center For Research Resources1990–1994
  • Short-Term Research TrainingNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1994
  • Trial Of Zvd VS DDI VS Zvd+Ddi In Symptomatic HIV Infected ChildrenNational Center For Research Resources1993
  • Safety And Tolerance Of Oral Zidovudine In Pregnancy HIV Infected WomenNational Center For Research Resources1993
  • Pyrimethamine Pharmacokinetics In HIV+ Patients Seropotive For T. GondiNational Center For Research Resources1993
  • 2'3'-Dideoxyinosine And Zidovudine In The Therapy Of Patients With AIDS Or ARCNational Center For Research Resources1993
  • Two Doses Of 2', Or 3'-Ddc In Treatment Of Children Intolerant To ZDVNational Center For Research Resources1992–1993
  • Randomized Study Of DDC Alone Or Ddc/Zdv Combination VS Zidovudine AloneNational Center For Research Resources1992–1993
  • Primary Prophylaxis Of Cerebral Toxoplasmosis In Hiv-Infected PatientsNational Center For Research Resources1992–1993
  • Phase I Safety And Pharmacokinetics Study Of D4T In Patients With AIDS Or ARCNational Center For Research Resources1992–1993
  • High VS Low Dose Zidovudine Administered To Children With HIVNational Center For Research Resources1992–1993
  • Meta-Analysis Of The AIDS LiteratureNational Institute Of Mental Health1991–1993
  • Safety And Efficacy Of Zvd For Asymptomatic HIV Infected IndividualsNational Center For Research Resources1991–1993
  • Potential Of Low Dose Therapy With ZDV And Interferon Alpha 2ANational Center For Research Resources1991–1993
  • Efficacy Of 2'3'Ddi Given Orally 2/Day To Patients With AIDS Or ARCNational Center For Research Resources1991–1993
  • Anti-Pneumocystis Agents PLUS ZDV For Prevention Of Serious InfectionsNational Center For Research Resources1991–1993
  • Establishment Of AIDS Treatment Evaluation UnitNational Institute Of Allergy And Infectious Diseases1992
  • Pyrimethamine Pharmacokinetics In HIV+ Patients Seropotivie For T GondiNational Center For Research Resources1992
  • Comparison Of 2',3'-Ddi Given Orally 2/Day To Patients With AIDS Or ARCNational Center For Research Resources1992
  • AZT In Treatment Of HIV Infection In Hemophilic PatientsNational Center For Research Resources1992
  • Safety/Efficicy Of ZDV In Therapy Of Patients With Early ARCNational Center For Research Resources1991–1992
  • Pediatric AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1988–1992
  • Phase II Study Comparing 2'3'-Ddi And Zivoduine Therapy In PTS With AIDS Or ARCNational Center For Research Resources1991
  • Foscarnet Salvage Therapy For AIDS Patients With Sight Threatening CMV RetinitisNational Center For Research Resources1991
  • Comparison Of 2',3'-Ddi Given Oraly 2/Day To Patients With AIDS Or ARCNational Center For Research Resources1991
  • Fluconqzole And Amphotaercin B In AIDS Patients With Crytococcal MeningitisNational Center For Research Resources1990–1991
  • Placebo Controlled Trial To Evaluate ZDV In Treatment Of HIV In Hemophilic PTSNational Center For Research Resources1989–1991
  • PCP In Aids--Trimetrexae With Leacovorin CA Rescue VS Trimethoprim/SulfamethoxNational Center For Research Resources1989–1991
  • The Establishment Of AIDS Treatment Evaluation UnitNational Institute Of Allergy And Infectious Diseases1988–1991
  • Phase I Safety &Pharmacokinetics Of D4T In Patients With AIDS Or ARCNational Center For Research Resources1990
  • Phase ONE Study Of As-101 In Patients With AIDS And ARCNational Center For Research Resources1989–1990
  • PCP In Aids--Aerosolized Pentamidine VS Parental/Oral Trimethrapin-SulfamethoxNational Center For Research Resources1989
  • Fluconqzole And Amphotaercin B In AIDS PTS. With Crytococcal MeningitisNational Center For Research Resources1989
  • Ateu 2:Azt In Treatment Of HIV Infection With AIDS Post First EpisodeNational Center For Research Resources1988
  • Aeu1:Azt In Treatment Of HIV Infection With Aids-Associated Kaposi'S SarcomaNational Center For Research Resources1988

Hospital Affiliations